A
Arysta Life Science
Development, marketing and distribution of chemical solutions for agroscience and health & nutrition science marketplace
About Arysta Life Science
Arysta LifeScience was established in 2001 through the merger of the agrochemical and pharmaceutical business units of Tomen and Nichimen, two Japanese trading companies. Before its acquisition, the company operated as a global provider of agricultural solutions, specializing in crop protection and life science products. Its headquarters was located in Tokyo, Japan, reflecting its ambition for global market reach.
In February 2019, Arysta LifeScience was acquired by UPL Limited for approximately $4.2 billion, a transaction that positioned the newly formed entity as one of the top five agricultural solutions companies globally. The merger was a strategic move to combine Arysta's focus on specialty applications and tailored local solutions with UPL's extensive portfolio. The combined company operates under the name UPL, with a joint purpose called "OpenAg," an initiative to create an open-access agricultural network that fosters sustainable growth for the entire food chain.
The business model centers on providing an integrated portfolio of both patented and post-patent agricultural solutions. This includes a wide array of products such as crop protection chemicals, BioSolutions, and seed treatments that cover the entire crop value chain. The company serves farmers and growers across more than 130 countries, with a direct presence in 76 nations. Revenue is generated from the sale of its diverse product offerings, which cater to a variety of row and specialty crops. The product lineup features fungicides, herbicides, insecticides, and plant growth regulators. A notable offering is ProNutiva, a program that combines conventional crop protection with biosolutions to enhance crop yield and quality. Legacy Arysta products like SELECT, CAPTAN, and EVEREST continue to be part of the new UPL portfolio.
Source: Dealroom company dataAt a glance
- Founded
- 2001
- Headquarters
- Cary, United States
- Sector
- Food
- Outcome tier
- Unicorn$1–10B valuation tier
News
Open roles
Arysta Life Science in the Cary ecosystem
The Arysta Life Science office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
- OAOlympus Capital Holdings Asia
Source: Dealroom Talent Intelligence.
Global footprint
team presence
across markets
Patents
53 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
Market sentiment
An AI-synthesised read of the highest-engagement posts about Arysta Life Science on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Arysta Life Science on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.


